Log in to search using one of your social media accounts:


BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017

Conference Call and Webcast @ 8:30 a.m. Eastern Time Today NEW YORK and PETACH TIKVAH, Israel, March 8, 2018 -- (Healthcare Sales &Marketing Network) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technolog... Regenerative Medicine, Neurology BrainStorm Cell Therapeutics, NurOwn , stem cell, amyotrophic lateral sclerosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

More News: ALS | Brain | Conferences | Israel Health | Marketing | Middle East Health | Neurology | Pharmaceuticals | Stem Cell Therapy | Stem Cells